ArticleFukushima journal of medical science2026
Attenuated neurovirulence of dUTPase-deficient herpes simplex virus type 1 in suckling mice but not in newborn mice.
Article in Fukushima journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The HSV-1 UL50 gene encodes dUTPase (DUT), which dephosphorylates dUTP into dUMP, and its mutant strain is known to reduce neurovirulence in mice over 3 weeks old. Therefore, the UL50-deficient strain may be a candidate as a vaccine strain or viral vector. In this study, the UL50-deficient strain demonstrated reduced levels of replication in brain and neurovirulence compared to the wild strain in 4-week-old mice, but not in newborn mice. Furthermore, the expression level of cellular DUT in the mouse brain was not detectable in 4-week-old mice, but was detectable in newborn mice. In vitro experiments showed replication of the UL50-deficient strain was reduced due to the knockdown of cellular DUT. These results suggest that in actively dividing cells, such as the brain neurons of newborn mice, efficient cellular DUT expression helps with the sufficient replication of the UL50 mutant, resulting in the same level of neurovirulence as that in the wild type. However, in the brains of 4-week-old mice, DUT expression is insufficient, resulting in reduced neurovirulence of the UL50 mutant. These results suggest that when using the UL50 mutant strain as a vaccine or virus vector, it is necessary to pay attention to the timing of inoculation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.